VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q56985526 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000200.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q56985526‏
024 ‎‡a 0000-0001-9116-1376‏ ‎‡2 orcid‏
024 ‎‡a 8739730400‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q56985526‏
100 0 ‎‡a Pedro Rosa-Neto‏ ‎‡c researcher‏ ‎‡9 en‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a Pedro Rosa-Neto‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's [18F]FDG PET signal is driven by astroglial glutamate transport‏
670 ‎‡a Author's [18F]SiFA-isothiocyanate: a new highly effective radioactive labeling agent for lysine-containing proteins.‏
670 ‎‡a Author's A dataset of multiresolution functional brain parcellations in an elderly population with no or mild cognitive impairment‏
670 ‎‡a Author's A Kinome-Wide Selective Radiolabeled TrkB/C Inhibitor for in Vitro and in Vivo Neuroimaging: Synthesis, Preclinical Evaluation, and First-in-Human‏
670 ‎‡a Author's Age- and gender-related differences in the cortical anatomical network‏
670 ‎‡a Author's Age-related alterations in the modular organization of structural cortical network by using cortical thickness from MRI.‏
670 ‎‡a Author's alpha-[11C]Methyl-L-tryptophan trapping in the orbital and ventral medial prefrontal cortex of suicide attempters‏
670 ‎‡a Author's Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer's disease‏
670 ‎‡a Author's Amyloid-beta modulates the association between neurofilament light chain and brain atrophy in Alzheimer's disease‏
670 ‎‡a Author's Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease.‏
670 ‎‡a Author's Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer's disease model‏
670 ‎‡a Author's Anosognosia predicts default mode network hypometabolism and clinical progression to dementia‏
670 ‎‡a Author's APOEε4 potentiates the relationship between amyloid-β and tau pathologies‏
670 ‎‡a Author's Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: application to normal elderly and Alzheimer's disease participants‏
670 ‎‡a Author's Atlas-guided tract reconstruction for automated and comprehensive examination of the white matter anatomy‏
670 ‎‡a Author's Aβ-induced vulnerability propagates via the brain's default mode network‏
670 ‎‡a Author's Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer's disease progression‏
670 ‎‡a Author's Bi-directional Association of Cerebrospinal Fluid Immune Markers with Stage of Alzheimer's Disease Pathogenesis.‏
670 ‎‡a Author's Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts‏
670 ‎‡a Author's Brain regional alpha-[11C]methyl-L-tryptophan trapping, used as an index of 5-HT synthesis, in healthy adults: absence of an age effect‏
670 ‎‡a Author's Canadian Consensus Guidelines on Use of Amyloid Imaging in Canada: Update and Future Directions from the Specialized Task Force on Amyloid imaging in Canada‏
670 ‎‡a Author's Characterizing biomarker features of cognitively normal individuals with ventriculomegaly‏
670 ‎‡a Author's Cholinergic Depletion in Alzheimer's Disease Shown by [‏
670 ‎‡a Author's Cholinergic Depletion in Alzheimer's Disease Shown by [ (18) F]FEOBV Autoradiography‏
670 ‎‡a Author's Cholinergic modulation of binocular vision‏
670 ‎‡a Author's Cholinergic Potentiation Improves Perceptual-Cognitive Training of Healthy Young Adults in Three Dimensional Multiple Object Tracking‏
670 ‎‡a Author's Clinical applications of neuroimaging in patients with Alzheimer's disease: a review from the Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.‏
670 ‎‡a Author's Common Effects of Amnestic Mild Cognitive Impairment on Resting-State Connectivity Across Four Independent Studies‏
670 ‎‡a Author's Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist‏
670 ‎‡a Author's Concordance between in vivo and postmortem measurements of cholinergic denervation in rats using PET with [18F]FEOBV and choline acetyltransferase immunochemistry‏
670 ‎‡a Author's Consensus guidelines for lumbar puncture in patients with neurological diseases‏
670 ‎‡a Author's Correction: White Matter Abnormalities and Structural Hippocampal Disconnections in Amnestic Mild Cognitive Impairment and Alzheimer’s Disease.‏
670 ‎‡a Author's Correlation between serotonin synthesis and 5-HT1A receptor binding in the living human brain: a combined alpha-[11C]MT and [18F]MPPF positron emission tomography study‏
670 ‎‡a Author's CYP2C19 variant mitigates Alzheimer disease pathophysiology in vivo and postmortem‏
670 ‎‡a Author's Deficit in Central Auditory Processing as a Biomarker of Pre-Clinical Alzheimer's Disease‏
670 ‎‡a Author's Deficit in sustained attention following selective cholinergic lesion of the pedunculopontine tegmental nucleus in rat, as measured with both post-mortem immunocytochemistry and in vivo PET imaging with [¹⁸F]fluoroethoxybenzovesamicol‏
670 ‎‡a Author's Deletion of the mu opioid receptor gene in mice reshapes the reward-aversion connectome‏
670 ‎‡a Author's Dementia: Disclosure of results to participants in dementia research‏
670 ‎‡a Author's Design, construction, and validation of an MRI-compatible vibrotactile stimulator intended for clinical use.‏
670 ‎‡a Author's Developments in Tau PET Imaging‏
670 ‎‡a Author's Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative‏
670 ‎‡a Author's Dissociation between brain amyloid deposition and metabolism in early mild cognitive impairment‏
670 ‎‡a Author's Distinct increased metabotropic glutamate receptor type 5‏
670 ‎‡a Author's Distinct increased metabotropic glutamate receptor type 5 (mGluR5) in temporal lobe epilepsy with and without hippocampal sclerosis‏
670 ‎‡a Author's Effect of age on markers for monoaminergic neurons of normal and MPTP-lesioned rhesus monkeys: a multi-tracer PET study‏
670 ‎‡a Author's Effects of acute nicotine on hemodynamics and binding of [11C]raclopride to dopamine D2,3 receptors in pig brain‏
670 ‎‡a Author's Efficient radiosynthesis and preclinical evaluation of [18 F]FOMPyD as a positron emission tomography tracer candidate for TrkB/C receptor imaging‏
670 ‎‡a Author's Epistasis analysis links immune cascades and cerebral amyloidosis‏
670 ‎‡a Author's Ethical Considerations for the Use of Next-Generation Alzheimer Drugs in Symptomatic and At-Risk Patients‏
670 ‎‡a Author's First-in-Human Brain Imaging of [18F]TRACK, a PET tracer for Tropomyosin Receptor Kinases‏
670 ‎‡a Author's Fluid and imaging biomarkers for Alzheimer's disease: Where we stand and where to head to.‏
670 ‎‡a Author's Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians‏
670 ‎‡a Author's Gradients of dopamine D1- and D2/3-binding sites in the basal ganglia of pig and monkey measured by PET.‏
670 ‎‡a Author's Human brain white matter atlas: identification and assignment of common anatomical structures in superficial white matter‏
670 ‎‡a Author's Identification of [18F]TRACK, a Fluorine-18-Labeled Tropomyosin Receptor Kinase (Trk) Inhibitor for PET Imaging‏
670 ‎‡a Author's Identifying incipient dementia individuals using machine learning and amyloid imaging‏
670 ‎‡a Author's Imaging Alzheimer's disease pathophysiology with PET.‏
670 ‎‡a Author's Imaging biomarkers for amyloid: a new generation of probes and what lies ahead‏
670 ‎‡a Author's Imaging in vivo glutamate fluctuations with [‏
670 ‎‡a Author's Imaging in vivo glutamate fluctuations with [(11)C]ABP688: a GLT-1 challenge with ceftriaxone‏
670 ‎‡a Author's Impact of scale space search on age- and gender-related changes in MRI-based cortical morphometry‏
670 ‎‡a Author's In vivo and in vitro validation of reference tissue models for the mGluR(5) ligand [(11)C]ABP688.‏
670 ‎‡a Author's In vivo characterization of metabotropic glutamate receptor type 5 abnormalities in behavioral variant FTD.‏
670 ‎‡a Author's In vivo tracking of tau pathology using positron emission tomography (PET) molecular imaging in small animals‏
670 ‎‡a Author's Intact memory in TGF-β1 transgenic mice featuring chronic cerebrovascular deficit: recovery with pioglitazone‏
670 ‎‡a Author's Intermediate flortaucipir uptake is associated with Aβ-PET and CSF tau in asymptomatic adults‏
670 ‎‡a Author's INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease.‏
670 ‎‡a Author's Is ApoE ɛ 4 a good biomarker for amyloid pathology in late onset Alzheimer's disease?‏
670 ‎‡a Author's Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study‏
670 ‎‡a Author's Mapping neuroreceptors at work: on the definition and interpretation of binding potentials after 20 years of progress‏
670 ‎‡a Author's Mapping the amphetamine-evoked changes in [11C]raclopride binding in living rat using small animal PET: modulation by MAO-inhibition‏
670 ‎‡a Author's MDMA-evoked changes in [11C]raclopride and [11C]NMSP binding in living pig brain‏
670 ‎‡a Author's MDMA-evoked changes in cerebral blood flow in living porcine brain: correlation with hyperthermia‏
670 ‎‡a Author's Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression‏
670 ‎‡a Author's Metabotropic Glutamate Receptor Type 5‏
670 ‎‡a Author's Metabotropic Glutamate Receptor Type 5 (mGluR5) Cortical Abnormalities in Focal Cortical Dysplasia Identified In Vivo With [11C]ABP688 Positron-Emission Tomography (PET) Imaging‏
670 ‎‡a Author's Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder‏
670 ‎‡a Author's MicroPET imaging and transgenic models: a blueprint for Alzheimer's disease clinical research‏
670 ‎‡a Author's MicroPET imaging of 5-HT 1A receptors in rat brain: a test-retest [18F]MPPF study‏
670 ‎‡a Author's Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain‏
670 ‎‡a Author's Multi-level bootstrap analysis of stable clusters in resting-state fMRI.‏
670 ‎‡a Author's Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities.‏
670 ‎‡a Author's Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease‏
670 ‎‡a Author's No apparent effect of naproxen on CSF markers of innate immune activation.‏
670 ‎‡a Author's Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer's disease‏
670 ‎‡a Author's Odor identification as a biomarker of preclinical AD in older adults at risk‏
670 ‎‡a Author's PET imaging of cholinergic deficits in rats using [18F]fluoroethoxybenzovesamicol‏
670 ‎‡a Author's PET imaging of cholinergic deficits in rats using [18F]fluoroethoxybenzovesamicol ([18F]FEOBV).‏
670 ‎‡a Author's PET imaging with [¹⁸F]fluoroethoxybenzovesamicol‏
670 ‎‡a Author's PET imaging with [¹⁸F]fluoroethoxybenzovesamicol ([¹⁸F]FEOBV) following selective lesion of cholinergic pedunculopontine tegmental neurons in rat.‏
670 ‎‡a Author's Pioglitazone improves reversal learning and exerts mixed cerebrovascular effects in a mouse model of Alzheimer's disease with combined amyloid-β and cerebrovascular pathology‏
670 ‎‡a Author's Prevention strategies for Alzheimer's disease‏
670 ‎‡a Author's Principal component of explained variance: An efficient and optimal data dimension reduction framework for association studies‏
670 ‎‡a Author's Proximity to Parental Symptom Onset and Amyloid-β Burden in Sporadic Alzheimer Disease.‏
670 ‎‡a Author's Quantification of brain cholinergic denervation in Alzheimer's disease using PET imaging with [18F]-FEOBV.‏
670 ‎‡a Author's Radioligands for Tropomyosin Receptor Kinase‏
670 ‎‡a Author's Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography Imaging‏
670 ‎‡a Author's Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4)‏
670 ‎‡a Author's Reduced metabotropic glutamate receptor 5 in the Flinders Sensitive Line of rats, an animal model of depression: an autoradiographic study‏
670 ‎‡a Author's Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer's Dementia‏
670 ‎‡a Author's Remodeling of Neuronal Circuits After Reach Training in Chronic Capsular Stroke‏
670 ‎‡a Author's Resting state executive control network adaptations in amnestic mild cognitive impairment‏
670 ‎‡a Author's Revealing modular architecture of human brain structural networks by using cortical thickness from MRI.‏
670 ‎‡a Author's Role of emerging neuroimaging modalities in patients with cognitive impairment: a review from the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.‏
670 ‎‡a Author's Sensory-parietal cortical stimulation improves motor recovery in severe capsular infarct.‏
670 ‎‡a Author's Stability of alpha-[11C]methyl-L-tryptophan brain trapping in healthy male volunteers‏
670 ‎‡a Author's Subjective Cognitive Decline Is Associated With Altered Default Mode Network Connectivity in Individuals With a Family History of Alzheimer's Disease‏
670 ‎‡a Author's Superficially located white matter structures commonly seen in the human and the macaque brain with diffusion tensor imaging‏
670 ‎‡a Author's Synergistic interaction between amyloid and tau predicts the progression to dementia‏
670 ‎‡a Author's Syntheses and evaluation of carbon-11- and fluorine-18-radiolabeled pan-tropomyosin receptor kinase‏
670 ‎‡a Author's Syntheses and evaluation of carbon-11- and fluorine-18-radiolabeled pan-tropomyosin receptor kinase (Trk) inhibitors: exploration of the 4-aza-2-oxindole scaffold as Trk PET imaging agents‏
670 ‎‡a Author's Targeting Alzheimer's Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment.‏
670 ‎‡a Author's Test-retest resting-state fMRI in healthy elderly persons with a family history of Alzheimer's disease‏
670 ‎‡a Author's Test-retest stability of cerebral mGluR₅ quantification using [¹¹C]ABP688 and positron emission tomography in rats‏
670 ‎‡a Author's The prevalence and biomarkers' characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database‏
670 ‎‡a Author's Topographical distribution of amyloid-β, tau and atrophy in behavioral / dysexecutive AD patients‏
670 ‎‡a Author's Topographical distribution of amyloid-β, tau and atrophy in behavioral / dysexecutive AD patients‏
670 ‎‡a Author's Towards the PET radiotracer for p75 neurotrophin receptor: [(11)C]LM11A-24 shows biological activity in vitro, but unfavorable ex vivo and in vivo profile‏
670 ‎‡a Author's Towards tropomyosin-related kinase B (TrkB) receptor ligands for brain imaging with PET: radiosynthesis and evaluation of 2-(4-[(18)F]fluorophenyl)-7,8-dihydroxy-4H-chromen-4-one and 2-(4-([N-methyl-(11)C]-dimethylamino)phenyl)-7,8-dihydroxy-4H-chro‏
670 ‎‡a Author's Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging‏
670 ‎‡a Author's Transgenic mice overexpressing APP and transforming growth factor-beta1 feature cognitive and vascular hallmarks of Alzheimer's disease‏
670 ‎‡a Author's Uptake and binding of the serotonin 5-HT1A antagonist [18F]-MPPF in brain of rats: effects of the novel P-glycoprotein inhibitor tariquidar‏
670 ‎‡a Author's Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues‏
670 ‎‡a Author's Use of Animal Models in Molecular Imaging‏
670 ‎‡a Author's Validation of a Regression Technique for Segmentation of White Matter Hyperintensities in Alzheimer's Disease‏
670 ‎‡a Author's White matter abnormalities and structural hippocampal disconnections in amnestic mild cognitive impairment and Alzheimer's disease‏
909 ‎‡a (scopus) 8739730400‏ ‎‡9 1‏
909 ‎‡a (orcid) 0000000191161376‏ ‎‡9 1‏
919 ‎‡a micropetimagingof5ht1areceptorsinratbrainatestretestmppfstudy‏ ‎‡A MicroPET imaging of 5-HT 1A receptors in rat brain: a test-retest [18F]MPPF study‏ ‎‡9 1‏
919 ‎‡a multimodalimaginginratmodelrecapitulatesalzheimersdiseasebiomarkersabnormalities‏ ‎‡A Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities.‏ ‎‡9 1‏
919 ‎‡a micropetimagingandtransgenicmodelsablueprintforalzheimersdiseaseclinicalresearch‏ ‎‡A MicroPET imaging and transgenic models: a blueprint for Alzheimer's disease clinical research‏ ‎‡9 1‏
919 ‎‡a neuropsychiatricsymptomspredicthypometabolisminpreclinicalalzheimerdisease‏ ‎‡A Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease‏ ‎‡9 1‏
919 ‎‡a methylphenidateevokedchangesinstriataldopaminecorrelatewithinattentionandimpulsivityinadolescentswithattentiondeficithyperactivitydisorder‏ ‎‡A Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder‏ ‎‡9 1‏
919 ‎‡a metabotropicglutamatereceptortype5mglur5corticalabnormalitiesinfocalcorticaldysplasiaidentifiedinvivowithabp688positronemissiontomographypetimaging‏ ‎‡A Metabotropic Glutamate Receptor Type 5 (mGluR5) Cortical Abnormalities in Focal Cortical Dysplasia Identified In Vivo With [11C]ABP688 Positron-Emission Tomography (PET) Imaging‏ ‎‡9 1‏
919 ‎‡a metabotropicglutamatereceptortype5‏ ‎‡A Metabotropic Glutamate Receptor Type 5‏ ‎‡9 1‏
919 ‎‡a measurementofbrainregionalalphamethyl50tryptophantrappingasameasureofserotoninsynthesisinmedicationfreepatientswithmajordepression‏ ‎‡A Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression‏ ‎‡9 1‏
919 ‎‡a mdmaevokedchangesincerebralbloodflowinlivingporcinebraincorrelationwithhyperthermia‏ ‎‡A MDMA-evoked changes in cerebral blood flow in living porcine brain: correlation with hyperthermia‏ ‎‡9 1‏
919 ‎‡a mdmaevokedchangesinracloprideandnmspbindinginlivingpigbrain‏ ‎‡A MDMA-evoked changes in [11C]raclopride and [11C]NMSP binding in living pig brain‏ ‎‡9 1‏
919 ‎‡a mappingtheamphetamineevokedchangesinraclopridebindinginlivingratusingsmallanimalpetmodulationbymaoinhibition‏ ‎‡A Mapping the amphetamine-evoked changes in [11C]raclopride binding in living rat using small animal PET: modulation by MAO-inhibition‏ ‎‡9 1‏
919 ‎‡a mappingneuroreceptorsatworkonthedefinitionandinterpretationofbindingpotentialsafter20yearsofprogress‏ ‎‡A Mapping neuroreceptors at work: on the definition and interpretation of binding potentials after 20 years of progress‏ ‎‡9 1‏
919 ‎‡a longitudinalcerebrospinalfluidbiomarkertrajectoriesalongthealzheimersdiseasecontinuuminthebiomarkapdstudy‏ ‎‡A Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study‏ ‎‡9 1‏
919 ‎‡a isapoeɛ4agoodbiomarkerforamyloidpathologyinlateonsetalzheimersdisease‏ ‎‡A Is ApoE ɛ 4 a good biomarker for amyloid pathology in late onset Alzheimer's disease?‏ ‎‡9 1‏
919 ‎‡a intrepadarandomizedtrialofnaproxentoslowprogressofpresymptomaticalzheimerdisease‏ ‎‡A INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease.‏ ‎‡9 1‏
919 ‎‡a intermediateflortaucipiruptakeisassociatedwithaβpetandcsftauinasymptomaticadults‏ ‎‡A Intermediate flortaucipir uptake is associated with Aβ-PET and CSF tau in asymptomatic adults‏ ‎‡9 1‏
919 ‎‡a noapparenteffectofnaproxenoncsfmarkersofinnateimmuneactivation‏ ‎‡A No apparent effect of naproxen on CSF markers of innate immune activation.‏ ‎‡9 1‏
919 ‎‡a intactmemoryintgfβ1transgenicmicefeaturingchroniccerebrovasculardeficitrecoverywithpioglitazone‏ ‎‡A Intact memory in TGF-β1 transgenic mice featuring chronic cerebrovascular deficit: recovery with pioglitazone‏ ‎‡9 1‏
919 ‎‡a noninvasiveinvivohyperspectralimagingoftheretinaforpotentialbiomarkeruseinalzheimersdisease‏ ‎‡A Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer's disease‏ ‎‡9 1‏
919 ‎‡a invivotrackingoftaupathologyusingpositronemissiontomographypetmolecularimaginginsmallanimals‏ ‎‡A In vivo tracking of tau pathology using positron emission tomography (PET) molecular imaging in small animals‏ ‎‡9 1‏
919 ‎‡a invivocharacterizationofmetabotropicglutamatereceptortype5abnormalitiesinbehavioralvariantftd‏ ‎‡A In vivo characterization of metabotropic glutamate receptor type 5 abnormalities in behavioral variant FTD.‏ ‎‡9 1‏
919 ‎‡a odoridentificationasabiomarkerofpreclinicaladinolderadultsatrisk‏ ‎‡A Odor identification as a biomarker of preclinical AD in older adults at risk‏ ‎‡9 1‏
919 ‎‡a petimagingofcholinergicdeficitsinratsusingfluoroethoxybenzovesamicol‏ ‎‡A PET imaging of cholinergic deficits in rats using [18F]fluoroethoxybenzovesamicol‏ ‎‡9 1‏
919 ‎‡a invivoandinvitrovalidationofreferencetissuemodelsforthemglur5ligandabp688‏ ‎‡A In vivo and in vitro validation of reference tissue models for the mGluR(5) ligand [(11)C]ABP688.‏ ‎‡9 1‏
919 ‎‡a petimagingofcholinergicdeficitsinratsusingfluoroethoxybenzovesamicolfeobv‏ ‎‡A PET imaging of cholinergic deficits in rats using [18F]fluoroethoxybenzovesamicol ([18F]FEOBV).‏ ‎‡9 1‏
919 ‎‡a petimagingwithfluoroethoxybenzovesamicol‏ ‎‡A PET imaging with [¹⁸F]fluoroethoxybenzovesamicol‏ ‎‡9 1‏
919 ‎‡a petimagingwithfluoroethoxybenzovesamicolfeobvfollowingselectivelesionofcholinergicpedunculopontinetegmentalneuronsinrat‏ ‎‡A PET imaging with [¹⁸F]fluoroethoxybenzovesamicol ([¹⁸F]FEOBV) following selective lesion of cholinergic pedunculopontine tegmental neurons in rat.‏ ‎‡9 1‏
919 ‎‡a impactofscalespacesearchonageandgenderrelatedchangesinmribasedcorticalmorphometry‏ ‎‡A Impact of scale space search on age- and gender-related changes in MRI-based cortical morphometry‏ ‎‡9 1‏
919 ‎‡a pioglitazoneimprovesreversallearningandexertsmixedcerebrovasculareffectsinamousemodelofalzheimersdiseasewithcombinedamyloidβandcerebrovascularpathology‏ ‎‡A Pioglitazone improves reversal learning and exerts mixed cerebrovascular effects in a mouse model of Alzheimer's disease with combined amyloid-β and cerebrovascular pathology‏ ‎‡9 1‏
919 ‎‡a preventionstrategiesforalzheimersdisease‏ ‎‡A Prevention strategies for Alzheimer's disease‏ ‎‡9 1‏
919 ‎‡a imaginginvivoglutamatefluctuationswithabp688aglt1challengewithceftriaxone‏ ‎‡A Imaging in vivo glutamate fluctuations with [(11)C]ABP688: a GLT-1 challenge with ceftriaxone‏ ‎‡9 1‏
919 ‎‡a imaginginvivoglutamatefluctuationswith‏ ‎‡A Imaging in vivo glutamate fluctuations with [‏ ‎‡9 1‏
919 ‎‡a imagingbiomarkersforamyloidanewgenerationofprobesandwhatliesahead‏ ‎‡A Imaging biomarkers for amyloid: a new generation of probes and what lies ahead‏ ‎‡9 1‏
919 ‎‡a imagingalzheimersdiseasepathophysiologywithpet‏ ‎‡A Imaging Alzheimer's disease pathophysiology with PET.‏ ‎‡9 1‏
919 ‎‡a identifyingincipientdementiaindividualsusingmachinelearningandamyloidimaging‏ ‎‡A Identifying incipient dementia individuals using machine learning and amyloid imaging‏ ‎‡9 1‏
919 ‎‡a identificationoftrackafluorine18labeledtropomyosinreceptorkinasetrkinhibitorforpetimaging‏ ‎‡A Identification of [18F]TRACK, a Fluorine-18-Labeled Tropomyosin Receptor Kinase (Trk) Inhibitor for PET Imaging‏ ‎‡9 1‏
919 ‎‡a humanbrainwhitematteratlasidentificationandassignmentofcommonanatomicalstructuresinsuperficialwhitematter‏ ‎‡A Human brain white matter atlas: identification and assignment of common anatomical structures in superficial white matter‏ ‎‡9 1‏
919 ‎‡a gradientsofdopamined1andd23bindingsitesinthebasalgangliaofpigandmonkeymeasuredbypet‏ ‎‡A Gradients of dopamine D1- and D2/3-binding sites in the basal ganglia of pig and monkey measured by PET.‏ ‎‡9 1‏
919 ‎‡a fluidbiomarkersfordiagnosingdementiarationaleandthecanadianconsensusondiagnosisandtreatmentofdementiarecommendationsforcanadianphysicians‏ ‎‡A Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians‏ ‎‡9 1‏
919 ‎‡a fluidandimagingbiomarkersforalzheimersdiseasewherewestandandwheretoheadto‏ ‎‡A Fluid and imaging biomarkers for Alzheimer's disease: Where we stand and where to head to.‏ ‎‡9 1‏
919 ‎‡a 1inhumanbrainimagingoftrackapettracerfortropomyosinreceptorkinases‏ ‎‡A First-in-Human Brain Imaging of [18F]TRACK, a PET tracer for Tropomyosin Receptor Kinases‏ ‎‡9 1‏
919 ‎‡a ethicalconsiderationsfortheuseofnextgenerationalzheimerdrugsinsymptomaticandatriskpatients‏ ‎‡A Ethical Considerations for the Use of Next-Generation Alzheimer Drugs in Symptomatic and At-Risk Patients‏ ‎‡9 1‏
919 ‎‡a epistasisanalysislinksimmunecascadesandcerebralamyloidosis‏ ‎‡A Epistasis analysis links immune cascades and cerebral amyloidosis‏ ‎‡9 1‏
919 ‎‡a efficientradiosynthesisandpreclinicalevaluationoffompydasapositronemissiontomographytracercandidatefortrkb100receptorimaging‏ ‎‡A Efficient radiosynthesis and preclinical evaluation of [18 F]FOMPyD as a positron emission tomography tracer candidate for TrkB/C receptor imaging‏ ‎‡9 1‏
919 ‎‡a effectsofacutenicotineonhemodynamicsandbindingofraclopridetodopamined23receptorsinpigbrain‏ ‎‡A Effects of acute nicotine on hemodynamics and binding of [11C]raclopride to dopamine D2,3 receptors in pig brain‏ ‎‡9 1‏
919 ‎‡a effectofageonmarkersformonoaminergicneuronsofnormalandmptplesionedrhesusmonkeysamultitracerpetstudy‏ ‎‡A Effect of age on markers for monoaminergic neurons of normal and MPTP-lesioned rhesus monkeys: a multi-tracer PET study‏ ‎‡9 1‏
919 ‎‡a distinctincreasedmetabotropicglutamatereceptortype5mglur5intemporallobeepilepsywithandwithouthippocampalsclerosis‏ ‎‡A Distinct increased metabotropic glutamate receptor type 5 (mGluR5) in temporal lobe epilepsy with and without hippocampal sclerosis‏ ‎‡9 1‏
919 ‎‡a distinctincreasedmetabotropicglutamatereceptortype5‏ ‎‡A Distinct increased metabotropic glutamate receptor type 5‏ ‎‡9 1‏
919 ‎‡a dissociationbetweenbrainamyloiddepositionandmetabolisminearlymildcognitiveimpairment‏ ‎‡A Dissociation between brain amyloid deposition and metabolism in early mild cognitive impairment‏ ‎‡9 1‏
919 ‎‡a diagnosticperformanceandpredictionofclinicalprogressionofplasmaphosphotau181inthealzheimersdiseaseneuroimaginginitiative‏ ‎‡A Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative‏ ‎‡9 1‏
919 ‎‡a developmentsintaupetimaging‏ ‎‡A Developments in Tau PET Imaging‏ ‎‡9 1‏
919 ‎‡a designconstructionandvalidationofanmricompatiblevibrotactilestimulatorintendedforclinicaluse‏ ‎‡A Design, construction, and validation of an MRI-compatible vibrotactile stimulator intended for clinical use.‏ ‎‡9 1‏
919 ‎‡a dementiadisclosureofresultstoparticipantsindementiaresearch‏ ‎‡A Dementia: Disclosure of results to participants in dementia research‏ ‎‡9 1‏
919 ‎‡a deletionofthemuopioidreceptorgeneinmicereshapestherewardaversionconnectome‏ ‎‡A Deletion of the mu opioid receptor gene in mice reshapes the reward-aversion connectome‏ ‎‡9 1‏
919 ‎‡a deficitinsustainedattentionfollowingselectivecholinergiclesionofthepedunculopontinetegmentalnucleusinratasmeasuredwithbothpostmortemimmunocytochemistryandinvivopetimagingwithfluoroethoxybenzovesamicol‏ ‎‡A Deficit in sustained attention following selective cholinergic lesion of the pedunculopontine tegmental nucleus in rat, as measured with both post-mortem immunocytochemistry and in vivo PET imaging with [¹⁸F]fluoroethoxybenzovesamicol‏ ‎‡9 1‏
919 ‎‡a deficitincentralauditoryprocessingasabiomarkerofpreclinicalalzheimersdisease‏ ‎‡A Deficit in Central Auditory Processing as a Biomarker of Pre-Clinical Alzheimer's Disease‏ ‎‡9 1‏
919 ‎‡a cyp2c19variantmitigatesalzheimerdiseasepathophysiologyinvivoandpostmortem‏ ‎‡A CYP2C19 variant mitigates Alzheimer disease pathophysiology in vivo and postmortem‏ ‎‡9 1‏
919 ‎‡a correlationbetweenserotoninsynthesisand5ht1areceptorbindinginthelivinghumanbrainacombinedalphamtandmppfpositronemissiontomographystudy‏ ‎‡A Correlation between serotonin synthesis and 5-HT1A receptor binding in the living human brain: a combined alpha-[11C]MT and [18F]MPPF positron emission tomography study‏ ‎‡9 1‏
919 ‎‡a correctionwhitematterabnormalitiesandstructuralhippocampaldisconnectionsinamnesticmildcognitiveimpairmentandalzheimersdisease‏ ‎‡A Correction: White Matter Abnormalities and Structural Hippocampal Disconnections in Amnestic Mild Cognitive Impairment and Alzheimer’s Disease.‏ ‎‡9 1‏
919 ‎‡a principalcomponentofexplainedvarianceanefficientandoptimaldatadimensionreductionframeworkforassociationstudies‏ ‎‡A Principal component of explained variance: An efficient and optimal data dimension reduction framework for association studies‏ ‎‡9 1‏
919 ‎‡a proximitytoparentalsymptomonsetandamyloidβburdeninsporadicalzheimerdisease‏ ‎‡A Proximity to Parental Symptom Onset and Amyloid-β Burden in Sporadic Alzheimer Disease.‏ ‎‡9 1‏
919 ‎‡a quantificationofbraincholinergicdenervationinalzheimersdiseaseusingpetimagingwithfeobv‏ ‎‡A Quantification of brain cholinergic denervation in Alzheimer's disease using PET imaging with [18F]-FEOBV.‏ ‎‡9 1‏
919 ‎‡a consensusguidelinesforlumbarpunctureinpatientswithneurologicaldiseases‏ ‎‡A Consensus guidelines for lumbar puncture in patients with neurological diseases‏ ‎‡9 1‏
919 ‎‡a concordancebetweeninvivoandpostmortemmeasurementsofcholinergicdenervationinratsusingpetwithfeobvandcholineacetyltransferaseimmunochemistry‏ ‎‡A Concordance between in vivo and postmortem measurements of cholinergic denervation in rats using PET with [18F]FEOBV and choline acetyltransferase immunochemistry‏ ‎‡9 1‏
919 ‎‡a completerescueofcerebrovascularfunctioninagedalzheimersdiseasetransgenicmicebyantioxidantsandpioglitazoneaperoxisomeproliferatoractivatedreceptorgammaagonist‏ ‎‡A Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist‏ ‎‡9 1‏
919 ‎‡a commoneffectsofamnesticmildcognitiveimpairmentonrestingstateconnectivityacross4independentstudies‏ ‎‡A Common Effects of Amnestic Mild Cognitive Impairment on Resting-State Connectivity Across Four Independent Studies‏ ‎‡9 1‏
919 ‎‡a clinicalapplicationsofneuroimaginginpatientswithalzheimersdiseaseareviewfromthe4canadianconsensusconferenceonthediagnosisandtreatmentofdementia‏ ‎‡A Clinical applications of neuroimaging in patients with Alzheimer's disease: a review from the Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.‏ ‎‡9 1‏
919 ‎‡a cholinergicpotentiationimprovesperceptualcognitivetrainingofhealthyyoungadultsin3dimensionalmultipleobjecttracking‏ ‎‡A Cholinergic Potentiation Improves Perceptual-Cognitive Training of Healthy Young Adults in Three Dimensional Multiple Object Tracking‏ ‎‡9 1‏
919 ‎‡a cholinergicmodulationofbinocularvision‏ ‎‡A Cholinergic modulation of binocular vision‏ ‎‡9 1‏
919 ‎‡a cholinergicdepletioninalzheimersdiseaseshownbyfeobvautoradiography‏ ‎‡A Cholinergic Depletion in Alzheimer's Disease Shown by [ (18) F]FEOBV Autoradiography‏ ‎‡9 1‏
919 ‎‡a cholinergicdepletioninalzheimersdiseaseshownby‏ ‎‡A Cholinergic Depletion in Alzheimer's Disease Shown by [‏ ‎‡9 1‏
919 ‎‡a characterizingbiomarkerfeaturesofcognitivelynormalindividualswithventriculomegaly‏ ‎‡A Characterizing biomarker features of cognitively normal individuals with ventriculomegaly‏ ‎‡9 1‏
919 ‎‡a canadianconsensusguidelinesonuseofamyloidimagingincanadaupdateandfuturedirectionsfromthespecializedtaskforceonamyloidimagingincanada‏ ‎‡A Canadian Consensus Guidelines on Use of Amyloid Imaging in Canada: Update and Future Directions from the Specialized Task Force on Amyloid imaging in Canada‏ ‎‡9 1‏
919 ‎‡a radioligandsfortropomyosinreceptorkinase‏ ‎‡A Radioligands for Tropomyosin Receptor Kinase‏ ‎‡9 1‏
919 ‎‡a brainregionalalphamethyl50tryptophantrappingusedasanindexof5htsynthesisinhealthyadultsabsenceofanageeffect‏ ‎‡A Brain regional alpha-[11C]methyl-L-tryptophan trapping, used as an index of 5-HT synthesis, in healthy adults: absence of an age effect‏ ‎‡9 1‏
919 ‎‡a radioligandsfortropomyosinreceptorkinasetrkpositronemissiontomographyimaging‏ ‎‡A Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography Imaging‏ ‎‡9 1‏
919 ‎‡a bloodphosphorylatedtau181asabiomarkerforalzheimersdiseaseadiagnosticperformanceandpredictionmodellingstudyusingdatafrom4prospectivecohorts‏ ‎‡A Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts‏ ‎‡9 1‏
919 ‎‡a recommendationsofthe4canadianconsensusconferenceonthediagnosisandtreatmentofdementiacccdtd4‏ ‎‡A Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4)‏ ‎‡9 1‏
919 ‎‡a bidirectionalassociationofcerebrospinalfluidimmunemarkerswithstageofalzheimersdiseasepathogenesis‏ ‎‡A Bi-directional Association of Cerebrospinal Fluid Immune Markers with Stage of Alzheimer's Disease Pathogenesis.‏ ‎‡9 1‏
919 ‎‡a reducedmetabotropicglutamatereceptor5intheflinderssensitivelineofratsananimalmodelofdepressionanautoradiographicstudy‏ ‎‡A Reduced metabotropic glutamate receptor 5 in the Flinders Sensitive Line of rats, an animal model of depression: an autoradiographic study‏ ‎‡9 1‏
919 ‎‡a aβ34isabace1deriveddegradationintermediateassociatedwithamyloidclearanceandalzheimersdiseaseprogression‏ ‎‡A Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer's disease progression‏ ‎‡9 1‏
919 ‎‡a regionalamyloidβloadandwhitematterabnormalitiescontributetohypometabolisminalzheimersdementia‏ ‎‡A Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer's Dementia‏ ‎‡9 1‏
919 ‎‡a aβinducedvulnerabilitypropagatesviathebrainsdefaultmodenetwork‏ ‎‡A Aβ-induced vulnerability propagates via the brain's default mode network‏ ‎‡9 1‏
919 ‎‡a atlasguidedtractreconstructionforautomatedandcomprehensiveexaminationofthewhitematteranatomy‏ ‎‡A Atlas-guided tract reconstruction for automated and comprehensive examination of the white matter anatomy‏ ‎‡9 1‏
919 ‎‡a atlasbasedwholebrainwhitematteranalysisusinglargedeformationdiffeomorphicmetricmappingapplicationtonormalelderlyandalzheimersdiseaseparticipants‏ ‎‡A Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: application to normal elderly and Alzheimer's disease participants‏ ‎‡9 1‏
919 ‎‡a apoeε4potentiatestherelationshipbetweenamyloidβandtaupathologies‏ ‎‡A APOEε4 potentiates the relationship between amyloid-β and tau pathologies‏ ‎‡9 1‏
919 ‎‡a anosognosiapredictsdefaultmodenetworkhypometabolismandclinicalprogressiontodementia‏ ‎‡A Anosognosia predicts default mode network hypometabolism and clinical progression to dementia‏ ‎‡9 1‏
919 ‎‡a angiotensin2type1receptorblockerlosartanpreventsandrescuescerebrovascularneuropathologicalandcognitivedeficitsinanalzheimersdiseasemodel‏ ‎‡A Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer's disease model‏ ‎‡9 1‏
919 ‎‡a amyloidβandhyperphosphorylatedtausynergydrivesmetabolicdeclineinpreclinicalalzheimersdisease‏ ‎‡A Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease.‏ ‎‡9 1‏
919 ‎‡a amyloidbetamodulatestheassociationbetweenneurofilamentlightchainandbrainatrophyinalzheimersdisease‏ ‎‡A Amyloid-beta modulates the association between neurofilament light chain and brain atrophy in Alzheimer's disease‏ ‎‡9 1‏
919 ‎‡a amyloidandtausignaturesofbrainmetabolicdeclineinpreclinicalalzheimersdisease‏ ‎‡A Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer's disease‏ ‎‡9 1‏
919 ‎‡a alphamethyl50tryptophantrappingintheorbitalandventralmedialprefrontalcortexofsuicideattempters‏ ‎‡A alpha-[11C]Methyl-L-tryptophan trapping in the orbital and ventral medial prefrontal cortex of suicide attempters‏ ‎‡9 1‏
919 ‎‡a remodelingofneuronalcircuitsafterreachtraininginchroniccapsularstroke‏ ‎‡A Remodeling of Neuronal Circuits After Reach Training in Chronic Capsular Stroke‏ ‎‡9 1‏
919 ‎‡a restingstateexecutivecontrolnetworkadaptationsinamnesticmildcognitiveimpairment‏ ‎‡A Resting state executive control network adaptations in amnestic mild cognitive impairment‏ ‎‡9 1‏
919 ‎‡a revealingmodulararchitectureofhumanbrainstructuralnetworksbyusingcorticalthicknessfrommri‏ ‎‡A Revealing modular architecture of human brain structural networks by using cortical thickness from MRI.‏ ‎‡9 1‏
919 ‎‡a roleofemergingneuroimagingmodalitiesinpatientswithcognitiveimpairmentareviewfromthecanadianconsensusconferenceonthediagnosisandtreatmentofdementia‏ ‎‡A Role of emerging neuroimaging modalities in patients with cognitive impairment: a review from the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.‏ ‎‡9 1‏
919 ‎‡a sensoryparietalcorticalstimulationimprovesmotorrecoveryinseverecapsularinfarct‏ ‎‡A Sensory-parietal cortical stimulation improves motor recovery in severe capsular infarct.‏ ‎‡9 1‏
919 ‎‡a stabilityofalphamethyl50tryptophanbraintrappinginhealthymalevolunteers‏ ‎‡A Stability of alpha-[11C]methyl-L-tryptophan brain trapping in healthy male volunteers‏ ‎‡9 1‏
919 ‎‡a agerelatedalterationsinthemodularorganizationofstructuralcorticalnetworkbyusingcorticalthicknessfrommri‏ ‎‡A Age-related alterations in the modular organization of structural cortical network by using cortical thickness from MRI.‏ ‎‡9 1‏
919 ‎‡a ageandgenderrelateddifferencesinthecorticalanatomicalnetwork‏ ‎‡A Age- and gender-related differences in the cortical anatomical network‏ ‎‡9 1‏
919 ‎‡a kinomewideselectiveradiolabeledtrkb100inhibitorforinvitroandinvivoneuroimagingsynthesispreclinicalevaluationand1inhuman‏ ‎‡A A Kinome-Wide Selective Radiolabeled TrkB/C Inhibitor for in Vitro and in Vivo Neuroimaging: Synthesis, Preclinical Evaluation, and First-in-Human‏ ‎‡9 1‏
919 ‎‡a datasetofmultiresolutionfunctionalbrainparcellationsinanelderlypopulationwithnoormildcognitiveimpairment‏ ‎‡A A dataset of multiresolution functional brain parcellations in an elderly population with no or mild cognitive impairment‏ ‎‡9 1‏
919 ‎‡a sifaisothiocyanateanewhighlyeffectiveradioactivelabelingagentforlysinecontainingproteins‏ ‎‡A [18F]SiFA-isothiocyanate: a new highly effective radioactive labeling agent for lysine-containing proteins.‏ ‎‡9 1‏
919 ‎‡a fdgpetsignalisdrivenbyastroglialglutamatetransport‏ ‎‡A [18F]FDG PET signal is driven by astroglial glutamate transport‏ ‎‡9 1‏
919 ‎‡a subjectivecognitivedeclineisassociatedwithaltereddefaultmodenetworkconnectivityinindividualswithafamilyhistoryofalzheimersdisease‏ ‎‡A Subjective Cognitive Decline Is Associated With Altered Default Mode Network Connectivity in Individuals With a Family History of Alzheimer's Disease‏ ‎‡9 1‏
919 ‎‡a superficiallylocatedwhitematterstructurescommonlyseeninthehumanandthemacaquebrainwithdiffusiontensorimaging‏ ‎‡A Superficially located white matter structures commonly seen in the human and the macaque brain with diffusion tensor imaging‏ ‎‡9 1‏
919 ‎‡a synergisticinteractionbetweenamyloidandtaupredictstheprogressiontodementia‏ ‎‡A Synergistic interaction between amyloid and tau predicts the progression to dementia‏ ‎‡9 1‏
919 ‎‡a synthesesandevaluationofcarbon11andfluorine18radiolabeledpantropomyosinreceptorkinase‏ ‎‡A Syntheses and evaluation of carbon-11- and fluorine-18-radiolabeled pan-tropomyosin receptor kinase‏ ‎‡9 1‏
919 ‎‡a synthesesandevaluationofcarbon11andfluorine18radiolabeledpantropomyosinreceptorkinasetrkinhibitorsexplorationofthe4aza2oxindolescaffoldastrkpetimagingagents‏ ‎‡A Syntheses and evaluation of carbon-11- and fluorine-18-radiolabeled pan-tropomyosin receptor kinase (Trk) inhibitors: exploration of the 4-aza-2-oxindole scaffold as Trk PET imaging agents‏ ‎‡9 1‏
919 ‎‡a targetingalzheimersdiseaseattherighttimeandtherightplacevalidationofapersonalizedapproachtodiagnosisandtreatment‏ ‎‡A Targeting Alzheimer's Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment.‏ ‎‡9 1‏
919 ‎‡a testretestrestingstatefmriinhealthyelderlypersonswithafamilyhistoryofalzheimersdisease‏ ‎‡A Test-retest resting-state fMRI in healthy elderly persons with a family history of Alzheimer's disease‏ ‎‡9 1‏
919 ‎‡a testreteststabilityofcerebralmglur5quantificationusingabp688andpositronemissiontomographyinrats‏ ‎‡A Test-retest stability of cerebral mGluR₅ quantification using [¹¹C]ABP688 and positron emission tomography in rats‏ ‎‡9 1‏
919 ‎‡a prevalenceandbiomarkerscharacteristicofrapidlyprogressivealzheimersdiseasefromthealzheimersdiseaseneuroimaginginitiativedatabase‏ ‎‡A The prevalence and biomarkers' characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database‏ ‎‡9 1‏
919 ‎‡a topographicaldistributionofamyloidi2tauandatrophyinbehavioral‏ ‎‡A Topographical distribution of amyloid-β, tau and atrophy in behavioral / dysexecutive AD patients‏ ‎‡9 1‏
919 ‎‡a topographicaldistributionofamyloidβtauandatrophyinbehavioral‏ ‎‡A Topographical distribution of amyloid-β, tau and atrophy in behavioral / dysexecutive AD patients‏ ‎‡9 1‏
919 ‎‡a towardsthepetradiotracerforp75neurotrophinreceptorlm11a24showsbiologicalactivityinvitrobutunfavorableexvivoandinvivoprofile‏ ‎‡A Towards the PET radiotracer for p75 neurotrophin receptor: [(11)C]LM11A-24 shows biological activity in vitro, but unfavorable ex vivo and in vivo profile‏ ‎‡9 1‏
919 ‎‡a towardstropomyosinrelatedkinasebtrkbreceptorligandsforbrainimagingwithpetradiosynthesisandevaluationof24fluorophenyl78dihydroxy4hchromen41and24dimethylaminophenyl78dihydroxy4hchro‏ ‎‡A Towards tropomyosin-related kinase B (TrkB) receptor ligands for brain imaging with PET: radiosynthesis and evaluation of 2-(4-[(18)F]fluorophenyl)-7,8-dihydroxy-4H-chromen-4-one and 2-(4-([N-methyl-(11)C]-dimethylamino)phenyl)-7,8-dihydroxy-4H-chro‏ ‎‡9 1‏
919 ‎‡a trackingneuroinflammationinalzheimersdiseasetheroleofpositronemissiontomographyimaging‏ ‎‡A Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging‏ ‎‡9 1‏
919 ‎‡a transgenicmiceoverexpressingappandtransforminggrowthfactorbeta1featurecognitiveandvascularhallmarksofalzheimersdisease‏ ‎‡A Transgenic mice overexpressing APP and transforming growth factor-beta1 feature cognitive and vascular hallmarks of Alzheimer's disease‏ ‎‡9 1‏
919 ‎‡a uptakeandbindingoftheserotonin5ht1aantagonistmppfinbrainofratseffectsofthenovelpglycoproteininhibitortariquidar‏ ‎‡A Uptake and binding of the serotonin 5-HT1A antagonist [18F]-MPPF in brain of rats: effects of the novel P-glycoprotein inhibitor tariquidar‏ ‎‡9 1‏
919 ‎‡a useofamyloidpetacrossthespectrumofalzheimersdiseaseclinicalutilityandassociatedethicalissues‏ ‎‡A Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues‏ ‎‡9 1‏
919 ‎‡a useofanimalmodelsinmolecularimaging‏ ‎‡A Use of Animal Models in Molecular Imaging‏ ‎‡9 1‏
919 ‎‡a validationofaregressiontechniqueforsegmentationofwhitematterhyperintensitiesinalzheimersdisease‏ ‎‡A Validation of a Regression Technique for Segmentation of White Matter Hyperintensities in Alzheimer's Disease‏ ‎‡9 1‏
919 ‎‡a whitematterabnormalitiesandstructuralhippocampaldisconnectionsinamnesticmildcognitiveimpairmentandalzheimersdisease‏ ‎‡A White matter abnormalities and structural hippocampal disconnections in amnestic mild cognitive impairment and Alzheimer's disease‏ ‎‡9 1‏
919 ‎‡a monoamineoxidasebinhibitorselegilinereduces18fthk5351uptakeinthehumanbrain‏ ‎‡A Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain‏ ‎‡9 1‏
919 ‎‡a multilevelbootstrapanalysisofstableclustersinrestingstatefmri‏ ‎‡A Multi-level bootstrap analysis of stable clusters in resting-state fMRI.‏ ‎‡9 1‏
943 ‎‡a 201x‏ ‎‡A 2012‏ ‎‡9 2‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 ISNI|0000000069095969‏
996 ‎‡2 LC|n 2006219400‏
996 ‎‡2 BLBNB|000299269‏
996 ‎‡2 BLBNB|001536171‏
996 ‎‡2 SUDOC|169793095‏
996 ‎‡2 BLBNB|000254412‏
996 ‎‡2 BLBNB|001023699‏
996 ‎‡2 DNB|1056471646‏
996 ‎‡2 DNB|1052650694‏
996 ‎‡2 BLBNB|000445662‏
996 ‎‡2 LC|no2010112530‏
996 ‎‡2 BLBNB|001526026‏
996 ‎‡2 PTBNP|1425210‏
996 ‎‡2 SUDOC|19810183X‏
996 ‎‡2 LC|n 80006491‏
996 ‎‡2 LC|no2014117741‏
996 ‎‡2 BLBNB|000515125‏
996 ‎‡2 BLBNB|001464378‏
996 ‎‡2 SUDOC|07995720X‏
996 ‎‡2 ISNI|0000000051171409‏
996 ‎‡2 DNB|105704282X‏
996 ‎‡2 BNF|17088377‏
996 ‎‡2 DNB|1137472529‏
996 ‎‡2 ISNI|0000000088340579‏
996 ‎‡2 BLBNB|000191764‏
996 ‎‡2 BLBNB|000381991‏
996 ‎‡2 DNB|1056374594‏
996 ‎‡2 LC|n 2021251277‏
996 ‎‡2 BIBSYS|11037444‏
996 ‎‡2 BLBNB|000293628‏
996 ‎‡2 ISNI|0000000068997274‏
996 ‎‡2 NUKAT|n 2012046081‏
996 ‎‡2 BLBNB|001518696‏
996 ‎‡2 PTBNP|280962‏
996 ‎‡2 LC|n 82108516‏
996 ‎‡2 LC|n 99902282‏
996 ‎‡2 BIBSYS|13033175‏
996 ‎‡2 ISNI|0000000054131891‏
996 ‎‡2 LC|nb2013016565‏
996 ‎‡2 LC|no2004115533‏
996 ‎‡2 LC|no2016122475‏
996 ‎‡2 ISNI|0000000048609123‏
996 ‎‡2 BLBNB|001482136‏
996 ‎‡2 ISNI|0000000044367841‏
996 ‎‡2 LC|n 2021251413‏
996 ‎‡2 BLBNB|001420403‏
996 ‎‡2 PTBNP|1322192‏
996 ‎‡2 BLBNB|001532535‏
996 ‎‡2 RERO|A026624254‏
996 ‎‡2 ISNI|0000000042435150‏
996 ‎‡2 LC|no2005029894‏
996 ‎‡2 SUDOC|259884294‏
996 ‎‡2 PTBNP|1510203‏
996 ‎‡2 PTBNP|1888245‏
996 ‎‡2 BLBNB|000354387‏
996 ‎‡2 BLBNB|001511753‏
996 ‎‡2 DBC|87097968882893‏
996 ‎‡2 PTBNP|1794646‏
996 ‎‡2 LC|n 84238257‏
996 ‎‡2 J9U|987007376596605171‏
996 ‎‡2 BLBNB|001024163‏
996 ‎‡2 LC|no2017095705‏
996 ‎‡2 BLBNB|000472320‏
996 ‎‡2 LC|n 2012211136‏
996 ‎‡2 NUKAT|n 2018126036‏
996 ‎‡2 LC|n 85282865‏
996 ‎‡2 LC|n 2006084831‏
996 ‎‡2 PTBNP|1536646‏
996 ‎‡2 PTBNP|1597970‏
996 ‎‡2 SUDOC|234761806‏
996 ‎‡2 DNB|1135198721‏
996 ‎‡2 LC|no2022109614‏
996 ‎‡2 ISNI|0000000389803733‏
996 ‎‡2 DNB|1102141070‏
996 ‎‡2 BLBNB|000584137‏
996 ‎‡2 PTBNP|1360539‏
996 ‎‡2 BLBNB|001472247‏
996 ‎‡2 ISNI|0000000111861517‏
996 ‎‡2 BLBNB|001014808‏
996 ‎‡2 BLBNB|001552273‏
996 ‎‡2 BLBNB|001561452‏
996 ‎‡2 LC|n 2010183757‏
996 ‎‡2 BLBNB|001468836‏
996 ‎‡2 BNC|981058615417806706‏
996 ‎‡2 PTBNP|1795949‏
996 ‎‡2 PTBNP|1423231‏
996 ‎‡2 ISNI|0000000069199338‏
996 ‎‡2 BLBNB|000201458‏
996 ‎‡2 LC|n 88634057‏
996 ‎‡2 DNB|171419154‏
996 ‎‡2 LC|n 82151469‏
996 ‎‡2 SUDOC|236228005‏
996 ‎‡2 SUDOC|149672594‏
996 ‎‡2 BLBNB|000217190‏
996 ‎‡2 PTBNP|1620548‏
996 ‎‡2 ISNI|0000000034589483‏
996 ‎‡2 NTA|263277151‏
996 ‎‡2 BLBNB|000283072‏
996 ‎‡2 LC|n 2012211096‏
996 ‎‡2 BLBNB|000272449‏
996 ‎‡2 BLBNB|000165865‏
996 ‎‡2 SUDOC|176706127‏
996 ‎‡2 BLBNB|001485370‏
996 ‎‡2 BLBNB|000223233‏
996 ‎‡2 BLBNB|000545799‏
996 ‎‡2 LC|n 2016257728‏
996 ‎‡2 PTBNP|1869514‏
996 ‎‡2 LC|n 2014205253‏
996 ‎‡2 LC|no2006062263‏
996 ‎‡2 PTBNP|1705584‏
996 ‎‡2 BLBNB|000953059‏
996 ‎‡2 BLBNB|001460171‏
996 ‎‡2 J9U|987007412608505171‏
996 ‎‡2 DNB|122891897X‏
996 ‎‡2 PLWABN|9810598553405606‏
996 ‎‡2 RERO|A000121572‏
996 ‎‡2 ISNI|0000000072371119‏
996 ‎‡2 ISNI|000000003822238X‏
996 ‎‡2 LC|no 97046775‏
996 ‎‡2 ISNI|0000000024952138‏
996 ‎‡2 BLBNB|000549976‏
996 ‎‡2 ISNI|0000000069916165‏
996 ‎‡2 PTBNP|772509‏
996 ‎‡2 BLBNB|001455820‏
996 ‎‡2 ISNI|0000000377531582‏
996 ‎‡2 SUDOC|187747911‏
996 ‎‡2 SUDOC|199268339‏
996 ‎‡2 NTA|363431888‏
996 ‎‡2 ISNI|0000000038358017‏
996 ‎‡2 ISNI|0000000391619505‏
996 ‎‡2 BLBNB|000579993‏
996 ‎‡2 BLBNB|000405439‏
996 ‎‡2 ISNI|0000000079977930‏
996 ‎‡2 BLBNB|000625658‏
996 ‎‡2 BLBNB|001470305‏
996 ‎‡2 PTBNP|1338027‏
996 ‎‡2 DNB|1052053718‏
996 ‎‡2 ISNI|000000043037816X‏
996 ‎‡2 ISNI|0000000036432092‏
996 ‎‡2 DNB|1257892150‏
996 ‎‡2 DNB|139726322‏
996 ‎‡2 ISNI|0000000080496907‏
996 ‎‡2 BNE|XX1711276‏
996 ‎‡2 LC|n 2021251471‏
996 ‎‡2 ISNI|0000000432864313‏
996 ‎‡2 PTBNP|1656467‏
996 ‎‡2 BLBNB|000572506‏
996 ‎‡2 ISNI|000000008225387X‏
996 ‎‡2 BLBNB|000264042‏
996 ‎‡2 PTBNP|1759050‏
996 ‎‡2 LC|no2014057119‏
996 ‎‡2 PLWABN|9813285118905606‏
996 ‎‡2 DNB|1028996586‏
996 ‎‡2 LC|no 00013996‏
996 ‎‡2 ISNI|0000000384234332‏
996 ‎‡2 BLBNB|001540641‏
996 ‎‡2 BLBNB|000394434‏
996 ‎‡2 J9U|987007438549705171‏
996 ‎‡2 BLBNB|000272448‏
996 ‎‡2 CAOONL|ncf11015950‏
996 ‎‡2 ISNI|0000000078864993‏
996 ‎‡2 BLBNB|000346914‏
996 ‎‡2 BLBNB|000253066‏
996 ‎‡2 LC|no2015044717‏
996 ‎‡2 PTBNP|1548787‏
996 ‎‡2 LC|n 95920109‏
996 ‎‡2 ISNI|0000000070915645‏
996 ‎‡2 LC|n 2009063946‏
996 ‎‡2 BLBNB|000274237‏
996 ‎‡2 ISNI|0000000036091486‏
996 ‎‡2 BLBNB|000422719‏
996 ‎‡2 BLBNB|000403866‏
996 ‎‡2 SUDOC|122783409‏
996 ‎‡2 BLBNB|000536909‏
996 ‎‡2 PTBNP|1355907‏
996 ‎‡2 NSK|000704190‏
996 ‎‡2 SUDOC|159090482‏
996 ‎‡2 LC|no2008023943‏
996 ‎‡2 BLBNB|001129813‏
996 ‎‡2 ISNI|0000000070236941‏
996 ‎‡2 BLBNB|001548501‏
996 ‎‡2 LC|no2024084063‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏